Genesis Center for Clinical Research

San Diego, California 92103

0 studies enrolling now · 19 studies all time

What they study most

Contraception, Dyspareunia, Endometriosis, Hot Flashes, Hot Flushes, Menopause, Metrorrhagia, Overactive Bladder, Postmenopausal Vulvovaginal Atrophy, Recurrent Vulvovaginal Candidiasis, Uterine Fibroids, Vaginal Infection

Studies at this site

• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis — Stopped early
• Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) — Completed
• LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study — Completed
• A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy — Completed
• Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) — Stopped early
• 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms — Completed
• Efficacy and Safety Study of an Oral Contraceptive in Healthy Females — Completed
• Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids — Stopped early
• Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms — Withdrawn before enrolling
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding — Completed
• Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women. — Completed
• A Study of MF101 in Postmenopausal Women — Status unconfirmed